Development of late over early full donor chimerism (FDC) results in improved progression-free and overall survival in patients with advanced malignant lymphomas receiving nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT). Conference

Ting, DT, Dey, B, Chaudhary, A et al. (2005). Development of late over early full donor chimerism (FDC) results in improved progression-free and overall survival in patients with advanced malignant lymphomas receiving nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT). . BLOOD, 106(11), 1020A-1020A.

cited authors

  • Ting, DT; Dey, B; Chaudhary, A; Colby, C; Power, K; McAfee, S; Ballen, K; Attar, E; Saidman, S; Preffer, F; Sackstein, R; Shaffer, J; Sykes, M; Spitzer, TR

authors

date/time interval

  • December 10, 2005 -

publication date

  • November 16, 2005

webpage

published in

keywords

  • Hematology
  • Life Sciences & Biomedicine
  • Science & Technology

Location

  • Atlanta, GA

Conference

  • 47th Annual Meeting of the American-Society-of-Hematology

publisher

  • AMER SOC HEMATOLOGY

start page

  • 1020A

end page

  • 1020A

volume

  • 106

issue

  • 11